AstraZeneca and Emulate sign strategic agreement to advance Organ-on-Chips tech
AstraZeneca is embedding Emulate’s Organ-on-Chips technology – and scientists – within its laboratories to further develop the technology as part of a strategic agreement, “with the overall goal to accelerate drug discovery,” says exec.